Multaq Recall Lawsuit Attorney
Multaq® (or its generic form, dronedarone), an antiarrhythmia medication, has been linked to liver damage, liver failure, liver transplants and death. During the first two years the medication was available, about half a million prescriptions for Multaq were filled in the United States.
This medication is manufactured by Sanofi-aventis and is prescribed to patients with atrial fibrillation (a heart rhythm disorder resulting in fast and irregular heartbeat), or atrial flutter (a heart rhythm disorder resulting in a very fast heart beat), and other conditions associated with an increased risk of developing heart problems.
Multaq is marketed as a medication that will decrease the chances that individuals will require hospitalization to treat the heart conditions. The FDA has warned that Multaq may cause some patients to suffer severe liver damage or failure that may result in the need for a transplant. According to the FDA, the two cases of severe liver failure requiring transplantation occurred at 4.5 and 6 months after initiation of Multaq (dronedarone) in patients with previously normal hepatic serum enzymes. Both patients were female and approximately 70 years of age.
For a free legal consultation, call 800-285-4878
Multaq Injury Information
In July 2011, a Multaq study was suddenly halted after it was determined that users may be facing an increased risk of heart problems. Multaq was deemed too risky for heart patients involved in the study after data suggested side effects of the medication may cause a two-fold increase in the risk of cardiovascular problems, such as heart attacks, stroke and death, among older users with permanent atrial fibrillation.
In a letter to health care professionals, Sanofi-Aventis instructed doctors to tell patients to immediately report any symptoms suggestive of hepatic injury. According to the FDA, these include anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching.
Multaq Legal Help
As a result of Sanofi-Aventis’ failure to provide adequate information about the potential Multaq risks, individuals who suffered liver injury, heart attack, stroke or sudden death may be entitled to financial compensation for their injuries. If you or a loved one took Multaq and suffered injuries, contact my office immediately to speak with a member of our Multaq Lawsuit Injury Attorney staff to determine your legal rights.